Ann: Antimicrobial Data Published in Peer-Reviewed Journal, page-77

Jut another iron in the fire for us.. Well Done BOT.. from sleepless nights pondering if this was the right gamble to suddenly BOT been the centre of attention in the antimicrobial stage.. some seem disappointed that we got this additional news out the left field and were solely focused on the 1801 results ONLY, but BOT have gone why give you one dollar when we can give you two dollars..

So thinking to myself..(dangerous) I would highly doubt a major pharma is not currently in negotiating with Vinnie ATM..
Simply put -> the "delay" in 1801 is due to BOT holding off on one patients data so as not to force the ANN whilst V finalizes the sale of BOT.. in the last few weeks V hints big time of commercialisation in nearly every publication.. his last one been “Our Company is now primed to commercialise "... Here is to hoping we have something major within the next few weeks.. cause the big dogs will be sniffing this poodle big time..